Please assess the completion status of the following clinical trial:

Trial Title: Midodrine for Prophylaxis Against Post Spinal Hypotension in Elderly Population

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Elderly patients (\>65).~* ASA I-II-III.~* Scheduled for hip joint surgery under spinal anaesthesia~Exclusion Criteria:~* • Uncontrolled hypertension~  * Liver cell failure (child B or C).~ * Chronic renal failure on regular dialysis~ * Contraindications of spinal anaesthesia~ * History of allergy to midodrine~ * Cardiac morbidities (impaired contractility with ejection fraction \< 50%, heart block, arrhythmias, tight valvular lesions).~ * Acute renal disease, urinary retention~ * Patients on negative chronotropic drugs (such as beta blocker) or vasoconstrictor~ * Patients with glaucoma

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- control group (Type: PLACEBO_COMPARATOR): oral metoclopramide 10 mg, Metoclopramide tablet was chosen as a placebo because it has the same appearance of midodrine tablet with no cardiovascular effects
- Midodrine group (Type: ACTIVE_COMPARATOR): oral midodrine tablet (5 mg)

Based on this trial design, predict the completion outcome and termination type (if applicable).